Market closed · Next open: Monday 9:30 AM ET
Last update: Jul 24, 2026, 6:18 PM ET
The New York Times Company
$71.65 2.11% today
Market Closed

Why The New York Times Company (NYT) stock moved

Updated Jul 25, 2026

The New York Times Company (NYT) shares rose 2.1% to $71.65 as of July 25, 2026, a modest gain from the prior close of $70.17. BestStocks flagged the session as a major change for NYT. The move is tied to price move down. Below, we break down what changed for NYT, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

NYT climbed 2.1% to $71.65

NYT rose 2.1% in its latest session, moving from $70.17 to $71.65.

Material / EarningsLow confidence
Rel. volume
0.8×
Below Avg
Vs peers
No comparable peers
Market cap
$11.6B
New York Stock Exchange
Analyst target
$81
+13.0% vs price
Price chart
Jun 24 – Jul 24
EVVVVVVV$68$73$77Jun 24Jul 1Jul 10Jul 17Jul 24
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for The New York Times Company investors

For The New York Times Company investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 2.1% session move. Weighing against that: The New York Times Company (NYT) moved -2.75% from $75.04 to $72.98 on 2026-07-14; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $81.00, implying +13.0% upside from $71.65. BestStocks rates the overall signal quality low (42/100). With earnings roughly 11 days out, the next report is the most likely near-term test of the move.

NYT price reaction

NYT last traded at $71.65, up $1.48 (+2.11%) from the previous close of $70.17. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $68.57 and $76.71, and it currently sits about 38% of the way up that band.

Bullish and bearish analyst opinions on The New York Times Company (NYT)

The consensus analyst price target on The New York Times Company (NYT) is $81.00, 13.0% above the recent $71.65. Over the past 90 days analysts logged 0 upgrades, 5 maintains, and 0 downgrades. Here is how the bullish and bearish cases on NYT line up.

The bullish case

  • Wall Street's consensus price target of $81.00 implies +13.0% upside from $71.65.
  • The Street's most bullish target is $95.00 (+32.6%).
  • Material positive event.
  • Positive 2.1% session move.
  • The New York Times Company (NYT) moved +3.07% from $72.98 to $75.22 on 2026-07-15.

The bearish case

  • The most bearish analyst target is $63.00 (-12.1%).
  • The New York Times Company (NYT) moved -2.75% from $75.04 to $72.98 on 2026-07-14.
Bull vs bear balanceBullish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 25, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $81+13.0%
= 5 maintains
B of A Securities maintained Neutral · 2026-06-24
SEC filings watch
No recent filings
Peer context
NYT+2.1%

Previous notable changes for NYT

Activity2026-07-16+2.0%
The New York Times Company (NYT) moved +1.98% from $75.22 to $76.71 on 2026-07-16, reaching a new 30-day high. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Activity2026-07-15+3.1%
The New York Times Company (NYT) moved +3.07% from $72.98 to $75.22 on 2026-07-15. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical, with NYT reaching a new 30-day high on volume near its 5-day average.
Risk2026-07-14-2.7%
The New York Times Company (NYT) moved -2.75% from $75.04 to $72.98 on 2026-07-14. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Activity2026-07-13+0.1%
The New York Times Company (NYT) moved +0.11% from $74.96 to $75.04 on 2026-07-13, reaching a new 30-day high. Volume was 1.8x the 5-day average.
Upcoming catalysts & outlook
Next earnings
2026-08-05 (est.)
in 11 days
Thesis shift
Bullish Shift
bullish signal
Risk level
Medium
from change events

Frequently asked questions about NYT

Why did The New York Times Company (NYT) stock move?

NYT rose 2.1% to $71.65. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did NYT stock rise?

NYT gained 2.11% ($1.48) versus the prior close of $70.17, last trading at $71.65 on 0.8× average volume.

When is The New York Times Company's next earnings date?

NYT's next earnings report is estimated for 2026-08-05 — about 11 days away.

What is the analyst price target for NYT?

The consensus analyst price target for NYT is $81.00, about 13.0% above the current $71.65. Over the past 90 days, analysts recorded 0 upgrades, 5 maintains, and 0 downgrades.

How BestStocks tracks NYT

This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 10 tracked change events for NYT, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 25, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataFMP earnings & estimatesSEC EDGAR filingsAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.